CbdMD Ownership
| YCBD Stock | USD 0.47 0.01 2.17% |
Shares in Circulation | First Issued 2016-06-30 | Previous Quarter 3 M | Current Value 3.6 M | Avarage Shares Outstanding 1.1 M | Quarterly Volatility 960.4 K |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
CbdMD |
CbdMD Stock Ownership Analysis
About 19.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 0.57. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. cbdMD Inc recorded a loss per share of 10.9. The entity had not issued any dividends in recent years. The firm had 1:45 split on the 25th of April 2023. cbdMD, Inc. produces and distributes various cannabidiol products. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina. CbdMD operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on AMEX Exchange. It employs 105 people. For more information please call Ronan Kennedy at 704 445 3060 or visit https://www.cbdmd.com.Besides selling stocks to institutional investors, CbdMD also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different CbdMD's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align CbdMD's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
CbdMD Quarterly Liabilities And Stockholders Equity |
|
About 19.0% of cbdMD Inc are currently held by insiders. Unlike CbdMD's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against CbdMD's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of CbdMD's insider trades
cbdMD Inc Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CbdMD insiders, such as employees or executives, is commonly permitted as long as it does not rely on CbdMD's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases CbdMD insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Kennedy Thomas Ronan over a month ago Acquisition by Kennedy Thomas Ronan of 16667 shares of CbdMD subject to Rule 16b-3 | ||
Kennedy Thomas Ronan over two months ago Acquisition by Kennedy Thomas Ronan of 1000 shares of CbdMD at 270.0 subject to Rule 16b-3 | ||
Kennedy Thomas Ronan over two months ago Acquisition by Kennedy Thomas Ronan of 38465 shares of CbdMD at 270.0 subject to Rule 16b-3 | ||
Raines William F Iii over three months ago Acquisition by Raines William F Iii of 75000 shares of CbdMD subject to Rule 16b-3 | ||
Bradley Whitford over six months ago Disposition of tradable shares by Bradley Whitford of CbdMD subject to Rule 16b-3 | ||
Sellers Bakari T. over six months ago Acquisition by Sellers Bakari T. of 2000 shares of CbdMD at 0.93 subject to Rule 16b-3 | ||
Wiesehan John J Iii over six months ago Acquisition by Wiesehan John J Iii of 161550 shares of CbdMD at 2000000.0 subject to Rule 16b-3 | ||
Sellers Bakari T over a year ago Acquisition by Sellers Bakari T of 5000 shares of CbdMD subject to Rule 16b-3 |
CbdMD Outstanding Bonds
CbdMD issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. cbdMD Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most CbdMD bonds can be classified according to their maturity, which is the date when cbdMD Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| CHTR 6375 01 SEP 29 Corp BondUS1248EPCS01 | View | |
| CHTR 7375 01 MAR 31 Corp BondUS1248EPCT83 | View | |
| US1248EPCN14 Corp BondUS1248EPCN14 | View | |
| US1248EPCP61 Corp BondUS1248EPCP61 | View | |
| US1248EPCQ45 Corp BondUS1248EPCQ45 | View | |
| CCO HLDGS LLC Corp BondUS1248EPCK74 | View |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether cbdMD Inc is a strong investment it is important to analyze CbdMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CbdMD's future performance. For an informed investment choice regarding CbdMD Stock, refer to the following important reports:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in cbdMD Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CbdMD. If investors know CbdMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CbdMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (10.90) | Revenue Per Share 7.06 | Quarterly Revenue Growth (0.15) | Return On Assets (0.16) | Return On Equity (1.35) |
The market value of cbdMD Inc is measured differently than its book value, which is the value of CbdMD that is recorded on the company's balance sheet. Investors also form their own opinion of CbdMD's value that differs from its market value or its book value, called intrinsic value, which is CbdMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CbdMD's market value can be influenced by many factors that don't directly affect CbdMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CbdMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if CbdMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CbdMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.